[Prognosis of primary tumors of the bladder].
D000368:Aged; D000477:Alkylating Agents / Q000633:toxicity; D000588:Amines / Q000009:adverse effects / Q000378:metabolism / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell; D002994:Clofibrate / Q000633:toxicity; D004848:Epithelium / Q000473:pathology; D005260:Female; D005602:France; D006801:Humans; D006965:Hyperplasia; D008297:Male; D008875:Middle Aged; D009602:Nitrosamines / Q000633:toxicity; D009784:Occupational Diseases / Q000139:chemically induced / Q000191:economics / Q000517:prevention & control; D009787:Occupational Medicine / Q000592:standards; D011379:Prognosis; D012176:Retinoids / Q000627:therapeutic use; D012439:Saccharin / Q000633:toxicity; D012553:Schistosomiasis haematobia; D014364:Tryptophan / Q000633:toxicity; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D014942:Workers' Compensation / Q000331:legislation & jurisprudence
D000477:Alkylating Agents; D000588:Amines; D000970:Antineoplastic Agents; D009602:Nitrosamines; D012176:Retinoids; D014364:Tryptophan; D012439:Saccharin; D002994:Clofibrate
Pronostic des tumeurs primitives de la vessie.